Chinook Therapeutics (KDNY) Short Interest Ratio & Short Volume → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free KDNY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Chinook Therapeutics Short Interest DataCurrent Short Volume2,880,000 sharesPrevious Short Volume3,330,000 sharesChange Vs. Previous Month-13.51%Dollar Volume Sold Short$112.84 millionShort Interest Ratio / Days to Cover1.5Last Record DateJuly 31, 2023Outstanding Shares71,810,000 sharesPercentage of Shares Shorted4.01%Today's Trading Volume0 sharesAverage Trading Volume1,186,257 sharesToday's Volume Vs. Average0% Short Selling Chinook Therapeutics ? Sign up to receive the latest short interest report for Chinook Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKDNY Short Interest Over TimeKDNY Days to Cover Over TimeKDNY Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Chinook Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20232,880,000 shares $112.84 million -13.5%N/A1.5 $39.18 7/15/20233,330,000 shares $130.64 million +6.4%N/A2.4 $39.23 6/30/20233,130,000 shares $120.25 million +72.0%N/A2.2 $38.42 6/15/20231,820,000 shares $68.81 million -56.4%N/A1.4 $37.81 5/31/20234,170,000 shares $100.87 million -4.6%N/A6 $24.19 5/15/20234,370,000 shares $102.26 million +31.6%10.4%6.2 $23.40 Get the Latest News and Ratings for KDNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chinook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/20233,320,000 shares $66.43 million +6.1%8.0%5.3 $20.01 4/15/20233,130,000 shares $63.73 million -3.4%7.5%5.4 $20.36 3/31/20233,240,000 shares $75.01 million -5.3%N/A5.9 $23.15 3/15/20233,420,000 shares $75.62 million +21.7%N/A6.4 $22.11 2/28/20232,810,000 shares $61.31 million +2.6%N/A5.1 $21.82 2/15/20232,740,000 shares $60.88 million +13.7%N/A5.2 $22.22 1/31/20232,410,000 shares $60.90 million +9.1%N/A4.5 $25.27 1/15/20232,210,000 shares $57.42 million +5.7%N/A4 $25.98 12/30/20222,090,000 shares $54.76 million +0.5%N/A3.8 $26.20 12/15/20222,080,000 shares $51.60 million +10.6%N/A3.8 $24.81 11/30/20221,880,000 shares $42.58 million -6.9%N/A3.2 $22.65 11/15/20222,020,000 shares $43.33 million -18.6%N/A3.6 $21.45 10/31/20222,480,000 shares $53.94 million -3.5%N/A4.3 $21.75 10/15/20222,570,000 shares $49.27 million -8.2%N/A4.7 $19.17 9/30/20222,800,000 shares $55.05 million +21.7%N/A5.3 $19.66 9/15/20222,300,000 shares $49.59 million +8.5%N/A3.9 $21.56 8/31/20222,120,000 shares $44.10 million -2.3%N/A3.7 $20.80 8/15/20222,170,000 shares $45.59 million -16.2%N/A3.2 $21.01 7/31/20222,590,000 shares $47.94 million +2.0%N/A3.8 $18.51 7/15/20222,540,000 shares $47.35 million +25.1%N/A3.8 $18.64 6/30/20222,030,000 shares $35.50 million -9.0%N/A3.1 $17.49 6/15/20222,230,000 shares $37.53 million -0.9%N/A3.8 $16.83 5/31/20222,250,000 shares $34.16 million +56.3%N/A4.4 $15.18 5/15/20221,440,000 shares $20.12 million +6.7%N/A3.9 $13.97 4/30/20221,350,000 shares $20.43 million +4.7%N/A4.3 $15.13 4/15/20221,290,000 shares $20.36 million -9.8%N/A4.2 $15.78 3/31/20221,430,000 shares $23.39 million +5.2%N/A4.4 $16.36 3/15/20221,360,000 shares $17.34 million -1.5%N/A4 $12.75 2/28/20221,380,000 shares $17.61 million +6.2%N/A4 $12.76 2/15/20221,300,000 shares $16.89 million -9.1%N/A3.7 $12.99 1/31/20221,430,000 shares $18.45 million -3.4%N/A3.7 $12.90 1/15/20221,480,000 shares $21.40 million -0.7%N/A3.4 $14.46 12/31/20211,490,000 shares $24.30 million -14.9%N/A3.7 $16.31 12/15/20211,750,000 shares $27.30 million +14.4%N/A4.6 $15.60Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. KDNY Short Interest - Frequently Asked Questions What is Chinook Therapeutics' current short interest? Short interest is the volume of Chinook Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 2,880,000 shares of KDNY short. Learn More on Chinook Therapeutics' current short interest. What is a good short interest ratio for Chinook Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KDNY shares currently have a short interest ratio of 2.0. Learn More on Chinook Therapeutics's short interest ratio. Is Chinook Therapeutics' short interest increasing or decreasing? Chinook Therapeutics saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 2,880,000 shares, a drop of 13.5% from the previous total of 3,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Chinook Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Chinook Therapeutics: Crinetics Pharmaceuticals, Inc. (7.50%), RayzeBio, Inc. (2.32%), Verona Pharma plc (7.51%), Akero Therapeutics, Inc. (11.83%), 89bio, Inc. (11.77%), Icosavax, Inc. (0.99%), Gracell Biotechnologies Inc. (1.64%), ImmunoGen, Inc. (7.74%), Roivant Sciences Ltd. (8.18%), HUTCHMED (China) Limited (0.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Chinook Therapeutics stock? Short selling KDNY is an investing strategy that aims to generate trading profit from Chinook Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chinook Therapeutics? A short squeeze for Chinook Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KDNY, which in turn drives the price of the stock up even further. How often is Chinook Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KDNY, twice per month. The most recent reporting period available is July, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Crinetics Pharmaceuticals Short Squeeze RayzeBio Short Squeeze Verona Pharma Short Squeeze Akero Therapeutics Short Squeeze 89bio Short Squeeze Icosavax Short Squeeze Gracell Biotechnologies Short Squeeze ImmunoGen Short Squeeze Roivant Sciences Short Squeeze HUTCHMED Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KDNY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press